RAD
RAD Articles
Retail Metrics attributes the rather lackluster October U.S. same-store sales to unseasonably warm weather and “uninspiring fashion.”
Published:
Last Updated:
In a new report, the analysts at Credit Suisse go sector-by-sector in search of the best mid-cap stocks to buy now.
Published:
One thing retailers have -- or should have learned -- is not to underestimate the power of Apple in the consumer world.
Published:
Last Updated:
ThinkstockOctober 13, 2014: It’s hard to say what impact the Monday holiday had on equities. The major indexes bounced around before settling lower in the mid-afternoon. Here are four stocks among...
Published:
Last Updated:
Rite Aid reported better-than-expected second-quarter fiscal 2015 results before markets opened Wednesday morning.
Published:
Last Updated:
The UBS team highlights six top stocks that are seeing increased prescription volume since the implementation of parts of the Affordable Care Act.
Published:
Rite Aid Corp. (NYSE: RAD) has been an incredible turnaround story. Things went south in the late 1990s after massive leveraged growth, and it has only been in the past year or so that investors have...
Published:
Rite Aid's preliminary 2015 outlook and May sales data will come as a sharp blow in the turnaround, particularly when you consider how strong the sales figures had been in recent months.
Published:
ThinkstockStocks are still challenging all-time highs, and investors keep hearing that the bull market has now become a stock picker’s market. What this means is that investors still will try to...
Published:
These are the top Wall Street analyst upgrades, downgrades and initiations seen on Friday, May 23, 2014. They include Aflac, FireEye, Rite Aid, Northern Trust, PetSmart and State Street.
Published:
Rite Aid has moved back to profitability, and now it appears that the drug store chain's same-store sales report for April is the best comparable sales report in 10 years.
Published:
courtesy of RiteAidRite Aid Corporation (NYSE: RAD) recently received great accolades for its earnings, and Goldman Sachs even gave it an incredible upgrade. On top of the stock still screening...
Published:
On top of acquiring RediClinic on Thursday, the retail pharmacy operator Rite Aid announced earnings of $0.06 per share on revenues of roughly $6.6 billion. Rite Aid continues to please.
Published:
ThinkstockThis last week was not exactly a great week for the bull market. After the bull market has now officially turned five years old from its March 2009 bottom, the Dow Jones Industrial Average...
Published:
courtesy of RiteAidRite Aid Corporation (NYSE: RAD) is a turnaround which keeps on turning. That is the theory from Goldman Sachs at least. The brokerage firm upgraded shares of the retail drug store...
Published: